University of Tuzla Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial
2009
NCT01939652
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

University Clinical Center Tuzla | University of Tuzla

Active Ingredients

Drugs in Phase 4 Trials (3)

hyperici extractum oleosum (1 trial)

shepherd's purse extractum oleosum (1 trial)

tea (1 trial)

Drugs in Phase 1 Trials (1)

ringer's lactate (1 trial)

Drugs in Other Trials (2)

alpha-lipoic acid (1 trial)

amikacin (Amikin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 4)

Vaginitis (Phase 4)

Vaginosis, Bacterial (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6